Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats

European Journal of Pharmacology

Volumn 721, Issue 1-3, 2013, Pages 35-42

  Mohamed, Doaa I ^a   Elmelegy, Ahmed A M ^a   El Aziz, Lubna F A ^a   Abdel Kawy, Hala S ^a   El Samad, Abeer A Abd ^b   El Kharashi, Omnyah A ^a  

^a Ain Shams University   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Concanavalin A; Factor alpha; Fenofibrate; Malondialdehyde; Portal pressure; PPAR ; Tumor necrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; FENOFIBRATE; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; HEMATOLOGICAL PARAMETERS; HEPATITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT;

CONCANAVALIN A; FACTOR ALPHA; FENOFIBRATE; MALONDIALDEHYDE; PORTAL PRESSURE; PPARΑ; TUMOR NECROSIS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CONCANAVALIN A; FENOFIBRATE; HEPATITIS; LIVER; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PORTAL PRESSURE; PPAR ALPHA; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890114170     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.058     Document Type: Article

References (29)

1. J. Bancroft, and M. Gamble Theory and Practice of Histological Techniques 6th ed. 121 2008 Churchill Livingstone, Elsevier Philadelphia, PA (150 & 433)
2. Y. Cheng, S. Dharancy, M. Malapel, and P. Desreumaux Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor α and carnitine palmitoyl acyl-CoA transferase 1A World J. Gastroenterol. 11 48 2005 7591 7596 (Pubitemid 43168421)
3. M. Cindoruk, M. Kerem, T. Karakan, B. Salman, O. Akin, M. Alper, O. Erdem, and S. Unal Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study BMC Gastroenterol. 7 2007 44
4. P. Colville-Nash, D. Willis, J. Papworth, C. Freemantle, C. Lam, G. Andrews, and D. Willoughby The peroxisome proliferator-activated receptor α activator, Wy14, 643, is anti-inflammatory in vivo Inflammopharmacology 12 5-6 2005 493 504 (Pubitemid 41607353)
5. W.N. Cong, R.Y. Tao, J.Y. Tian, G.T. Liu, and F. Ye The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice Life Sci. 82 19-20 2008 983 990
6. S. Dharancy, M. Lemoine, P. Mathurin, L. Serfaty, and L. Dubuquoy Peroxisome proliferator-activated receptors in HCV-related infection PPAR Res. 2009 5 (V. 57204), (Article ID 357204)
7. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev. Immunol. 2 2002 748 759 (Pubitemid 37328715)
8. A. Erhardt, M. Biburger, T. Papadopoulos, and G. Tiegs IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice Hepatology 45 2 2007 475 485 (Pubitemid 46374604)
9. S.L. Friedman Liver fibrosis-from bench to bedside J. Hepatol. 38 1 2003 38 53
10. T.L. Goldsworthy, R. Fransson-Steen, R. Robert, and R.R. Maronpot Importance of and approaches to quantification of hepatocyte apoptosis Toxicol. Pathol. 24 1 1996 24 35 (Pubitemid 26066416)
11. A. Gottardi, V. Pazienza, P. Pugnale, F. Bruttin, L. Rubbia-Brandt, C.E. Juge-Aubry, C.A. Meier, A. Hadengue, and F. Negro Peroxisome proliferator-activated receptor-α and -γ mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection Aliment Pharmacol. Ther. 23 1 2006 107 114 (Pubitemid 43381173)
12. M. Hatano, S. Sasaki, S. Ohata, Y. Shiratsuchi, T. Yamazaki, K. Nagata, and Y. Kobayashi Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis Cell Immunol. 251 2008 25 30
13. J. Holoman, J. Glasa, S. Galbavy, D. Danis, A. Molnarova, J. Kazar, A. Bednarova, and J. Misianik Serum markers of liver fibrogenesis, and liver histology findings in patients with chronic liver diseases Bratisl. Lek. Listy. 103 2 2002 70 75
14. A. Kobayashi, Y. Suzuki, H. Kuno, S. Sugai, H. Sakakibara, and K. Shimoi Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats J. Toxicol. Sci. 34 4 2009 377 387
15. S. Kobayashi, S. Seki, N. Kawada, H. Morikawa, K. Nakatani, N. Uyama, K. Ikeda, Y. Nakajima, T. Arakawa, and K. Kaneda Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells Cell Tissue Res. 311 2003 353 364 (Pubitemid 36459674)
16. A. Kamiyoshi, T. Sakurai, Y. Ichikawa-Shindo, N. Iinuma, H. Kawate, T. Yoshizawa, T. Koyama, S. Muto, and T. Shindo Endogenous alpha-calcitonin gene-related peptid mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin a Liver Int. 29 5 2009 642 649
17. J.C. López-Talavera, A. Levitzki, M. Martínez, A. Gazit, R. Esteban, and J. Guardia Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites J. Clin. Invest. 100 3 1997 664 670 (Pubitemid 27340515)
18. T. Nakano, S. Goto, C.Y. Lai, L.W. Hsu, Y. Takaoka, S. Kawamoto, K.C. Chiang, Y. Shimada, N. Ohmor, T. Goto, S. Sato, K. Ono, Y.F. Cheng, and C.L. Chen Immunological aspects and therapeutic significance of an autoantibody against histone H1 in a rat model of concanavalin A-induced hepatitis Immunology 129 4 2010 547 555
19. J.M. Peters, I. Rusyn, M.L. Rose, F.J. Gonzalez, and R.G. Thurman Peroxisome proliferator-activated receptor α is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis Carcinogenesis 21 2000 823 826 (Pubitemid 30214043)
20. G. Rizzo, and S. Fiorucci PPARs and other nuclear receptors in inflammation Curr. Opin. Pharmacol. 6 4 2006 421 427
21. A. Rodríguez-Vilarrupla, B. Laviña, H. García- Calderó, L. Russo, E. Rosado, N. Roglans, J. Bosch, and J.C. García-Pagán PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats J. Hepatol. 56 5 2012 1033 1039
22. L. Sandrin, M. Tanter, J.L. Gennisson, S. Catheline, and M. Fink Shear elasticity probe for soft tissues with 1-D transient elastography IEEE Trans. Ultrason. Ferroelectr. Freq. Control 49 4 2002 436 446 (Pubitemid 34555341)
23. A. Schmitt-Gräff, S. Krüger, F. Bochard, G. Gabbiani, and H. Denk Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers Am. J. Pathol. 138 5 1991 1233 1242
24. R.F. Schwabe, and D.A. Brenner Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways Am. J. Physiol. Gastrointest. Liver Physiol. 290 4 2006 G583 G589
25. H. Shirin, H. Aeed, A. Alin, Z. Matas, M. Kirchner, E. Brazowski, I. Goldiner, and R. Bruck Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers Dig. Dis. Sci. 55 2 2010 268 275
26. Y.S. Seo, J.H. Kim, N.Y. Jo, K.M. Choi, S.H. Baik, J.J. Park, J.S. Kim, K.S. Byun, Y.T. Bak, C.H. Lee, A. Kim, and J.E. Yeon PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes J. Gastroenterol. Hepatol. 23 1 2008 102 109 (Pubitemid 350265194)
27. T. Toyama, H. Nakamura, Y. Harano, N. Yamauchi, A. Morita, T. Kirishima, M. Minami, and Y Itoh PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats Biochem. Biophys. Res. Commun. 324 2 2004 697 704 (Pubitemid 39345573)
28. K. Wallace, A.D. Burt, and M.C. Wright Liver fibrosis Biochem. J. 411 2008 1 18 (Pubitemid 351482341)
29. Y. Zhou, X. Jia, J. Qin, C. Lu, H. Zhu, X. Li, X. Han, and X. Sun Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage Mol. Cell. Endocrinol. 323 2 2010 193 200